Recently Viewed
Clear All₹33.42
As on 02-Apr-2026IST
Today’s Range
52 Week Range
Liquidity
Market cap
₹25 Cr
Revenue (TTM)
₹36 Cr
Net Profit (TTM)
₹-1 Cr
ROE
0 %
ROCE
-5.2 %
P/E Ratio
--
P/B Ratio
-8.3
Industry P/E
45.32
EV/EBITDA
28.2
Div. Yield
0 %
Debt to Equity
-5.6
Book Value
₹-4
EPS
₹-1.1
Face value
10
Shares outstanding
7,468,920
CFO
₹26.56 Cr
EBITDA
₹23.57 Cr
Net Profit
₹3.51 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
CMM Hospital
| -27.3 | -12.1 | -27.3 | 9.3 | 21.7 | 28.0 | 11.7 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
CMM Hospital
| 14.5 | 1.8 | 83.9 | -7.5 | 124.6 | 25.9 | -34.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
CMM Hospital
|
33.4 | 25.0 | 36.4 | -0.8 | -3.5 | -- | -- | -8.3 |
| 224.2 | 3,541.3 | 1,041.9 | 96.4 | 12.0 | 11.5 | 36.7 | 3.0 | |
| 658.1 | 34,139.0 | 4,461.2 | 397.5 | 13.4 | 9.1 | 104.4 | 7.4 | |
| 417.0 | 13,234.6 | 1,976.2 | 160.7 | 14.1 | 6.7 | 105 | 6.7 | |
| 527.7 | 7,890.6 | 2,478.2 | 24.7 | 8.4 | 4.2 | 416.4 | 5.9 | |
| 399.6 | 3,671.5 | 1,451.5 | 182.9 | 15.5 | 29.2 | 20.1 | 5.2 | |
| 1,229.1 | 8,107.9 | 1,433.4 | 188.7 | 17.4 | 13.8 | 43 | 5.4 | |
| 5,098.0 | 5,578.3 | 1,529.9 | 235.8 | 21.2 | 20.7 | 23.7 | 4.4 | |
| 1,149.5 | 11,675.2 | 1,613.3 | 259.9 | 23.0 | 17.3 | 45.3 | 7.3 | |
| 671.6 | 6,493.3 | 1,089.4 | 165.1 | 17.4 | 10.2 | 38.8 | 3.7 |
No Review & Analysis are available.
Chennai Meenakshi Multispeciality Hospital Limited operates a 100-bedded hospital in Chennai, India. The company offers services in the areas of cardiology, cosmetic and plastic surgery, diabetology, endocrinology, dermatology, dentistry, ENT,... surgical gastroenterology, general surgery, and gynecology. It also provides general medicine, vascular surgery, minimal access general and metabolic tumors surgery, neurology, neuro surgery, orthopedics, pediatrics, pediatric gastroenterology, ophthalmology, and pulmonology services. The company was formerly known as Devaki Hospital. Chennai Meenakshi Multispeciality Hospital Limited was incorporated in 1990 and is based in Chennai, India. Read more
Incorporated
1990
Chairman
R Gomathi
Managing Director
R Gomathi
Headquarters
Chennai, Tamil Nadu
Website
Annual Reports
Announcements
View AnnouncementsThe share price of Chennai Meenakshi Multispeciality Hospital Ltd is ₹33.42 (BSE) as of 02-Apr-2026 IST. Chennai Meenakshi Multispeciality Hospital Ltd has given a return of 21.68% in the last 3 years.
Since, TTM earnings of Chennai Meenakshi Multispeciality Hospital Ltd is negative, P/E ratio is not available.
The P/B ratio of Chennai Meenakshi Multispeciality Hospital Ltd is -8.27 times as on 02-Apr-2026, a 234 discount to its peers’ median range of 6.19 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
-12.21
|
|
2024
|
0.00
|
-76.92
|
|
2023
|
15.56
|
113.94
|
|
2022
|
4.35
|
-22.26
|
|
2021
|
0.00
|
-1.53
|
The 52-week high and low of Chennai Meenakshi Multispeciality Hospital Ltd are Rs 57.48 and Rs 29.47 as of 04-Apr-2026.
Chennai Meenakshi Multispeciality Hospital Ltd has a market capitalisation of ₹ 25 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Chennai Meenakshi Multispeciality Hospital Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.